DHR Continuing Medical Education Presents: Brush Country Medicine and Survival Conference

Translate to Spanish or other 102 languages!

Texas Border Business

- Advertisement -

South Texas is a premier location for hunting and fishing, yet many people are unaware of the hidden dangers that these sports present. The Brush Country Medicine Survival Conference will cover how to treat injuries and medical emergencies while in the brush country, such as snake bites, spider bites, poison ivy, gunshot wounds, heat related illness, drowning and other emergent issues that may arise. Faculty were chosen by expertise in their medical field.

Who Should Attend:
This course was designed for all physicians, allied health professionals, first responders, law enforcement officers, EMS, EMT, and firefighters as well as the local community.

Learning Objectives:
• Discuss how to treat injuries such as snake bites, spider bites, poison ivy, foot blisters.
• Recognize the approaches needed when faced with heat illness or frostbite.
• Review what to do in case of drowning/ near drowning.
• Identify what you need to survive in the brush country.
• Describe Texas Wildlife and Conservation guidelines.
• Discuss border safety when confronted by non-hunters.
• Identify the nearest medical facility for emergency treatment.

- Advertisement -

–Saturday, October 18, 2014
–8:00 AM – 12:00 PM
–Edinburg Conference Center at Renaissance
118 Paseo del Prado / Edinburg, TX 78539
–Tuition Fee: $100 MD, PA, NP
No Fee for First Responders, Law Enforcement Officers, Firefighters, EMS, EMT, or the general public.

For more information contact the Doctors Hospital at Renaissance Office of Continuing Medical Education at (956) 362-3240 or visit bit.ly/brushcountry

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -